Increased risk of neurodegenerative disorders was noted among COVID-19 positive outpatients.
Increased risk of neurodegenerative disorders was noted among COVID-19 positive outpatients. Out of the 919,731 individuals that tested for COVID-19 within the study, researchers found that the 43,375 people who tested positive had a 3.5 times increased risk of being diagnosed with Alzheimer’s disease, 2.6 times with Parkinson’s disease, 2.7 times with ischemic stroke and 4.8 times increased with intracerebral hemorrhage (bleeding in the brain).
‘People who had tested positive for COVID-19 were at an increased risk of Alzheimer’s disease, Parkinson’s disease, and ischemic stroke.’
While neuroinflammation may contribute to the accelerated development of neurodegenerative disorders, the authors also highlighted the implications of the scientific focus on long-term sequelae after COVID-19. The study analyzed in- and outpatients in Denmark between February 2020 and November 2021, as well as influenza patients from the corresponding pre-pandemic period. Researchers used statistical techniques to calculate relative risk, and results were stratified for hospitalization status, age, sex and comorbidities.
COVID-19 and Neurogenerative Disorders
Dr. Pardis Zarifkar, lead author from the Department of Neurology, Rigshospitalet, Copenhagen, Denmark, explained, “More than two years after the onset of the COVID-19 pandemic, the precise nature and evolution of the effects of COVID-19 on neurological disorders remained uncharacterized.Previous studies have established an association with neurological syndromes, but until now it is unknown whether COVID-19 also influences the incidence of specific neurological diseases and whether it differs from other respiratory infections.”
The increased risk of most neurological diseases was, however, no higher in COVID-19-positive patients than in people who had been diagnosed with influenza or other respiratory illnesses. COVID-19 patients had a 1.7 times increased risk of ischemic stroke compared to influenza and bacterial pneumonia inpatients over 80 years of age.
The frequency of other neurodegenerative illnesses such as multiple sclerosis, myasthenia gravis, Guillain-Barré syndrome and narcolepsy did not increase after COVID-19, influenza, or pneumonia.
Advertisement
“These findings will help inform our understanding of the long-term effect of COVID-19 on the body and the role that infections play in neurodegenerative diseases and stroke.”
Advertisement